WebDisclosure WebDisclosure
Basculer en Français
10054 Companies
205271 Keywords
135508 Articles
108829 Press releases
Headlines Articles Press releases BioNxt Solutions Inc. Remove
  1. Home
  2. Companies
  3. BioNxt Solutions Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 03/02/2023 at 22:30, 3 years ago

    BioNxt Solutions Announces Engagement Of Canaccord For Early Warrant Exercise Program

    Logo of BioNxt Solutions Inc.
  • PRESS RELEASE

    published on 03/01/2023 at 09:05, 3 years ago

    BioNxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson’s Disease

    Logo of BioNxt Solutions Inc.
  • PRESS RELEASE

    published on 02/13/2023 at 09:05, 3 years 1 month ago

    BioNxt Reports Update on Commercialization of Rotigotine Patch for Treatment of Parkinson's Disease

    Logo of BioNxt Solutions Inc.
Previous page
1 ... 22 23
Accesswire
  • Published on 03/19/2026 at 13:00, 15 minutes ago

    Dateline Secures Second Rig to Fast-Track Colosseum REE Program

  • Published on 03/19/2026 at 13:00, 15 minutes ago

    Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market

  • Published on 03/19/2026 at 13:00, 15 minutes ago

    CHAR Technologies Announces Closing of Previously Announced Private Placement, Initiation of New Marketing Efforts

  • Published on 03/19/2026 at 12:30, 45 minutes ago

    Algo Grande Launches Advanced Geophysical and Geochemical Programs Ahead of Phase II Drilling in Q2 2026

  • Published on 03/19/2026 at 12:30, 45 minutes ago

    Datavault AI Reports First Profitable Quarter, Record Revenue Growth, and Reiterates $200M (~400% YoY Growth) Full Year 2026 Revenue Target

View all ACCESSWIRE
EQS Group
  • Published on 03/19/2026 at 13:00, 15 minutes ago

    Secarna Pharmaceuticals establishes Advisory Board with financial markets expert Jens Holstein and shareholder representative Richard Mark Engelhard

  • Published on 03/19/2026 at 12:56, 19 minutes ago

    ABB Ltd: ABB shareholders approve all proposals at 2026 annual general meeting

  • Published on 03/19/2026 at 12:10, 1 hour 4 minutes ago

    ZPMC Completes First Emissions Rights Transaction in Shanghai

  • Published on 03/19/2026 at 12:05, 1 hour 9 minutes ago

    CD&R Expands Climate Leadership Program to Europe with Imperial College Business School and Extends Columbia University Partnership in the U.S. for Second Year

  • Published on 03/19/2026 at 12:05, 1 hour 9 minutes ago

    Amundi Physical Metals plc: UK Final Terms

View all EQS
Les Echos
  • Published on 03/19/2026 at 08:45, 4 hours 30 minutes ago

    Deezer et Sonos renouvellent et étendent leur partenariat stratégique

  • Published on 03/19/2026 at 08:45, 4 hours 30 minutes ago

    Deezer and Sonos renew and expand long-term collaboration

  • Published on 03/19/2026 at 07:00, 6 hours 15 minutes ago

    bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe

  • Published on 03/19/2026 at 07:00, 6 hours 15 minutes ago

    bioMérieux obtient le marquage CE IVDR pour deux tests BIOFIRE® SPOTFIRE® afin de renforcer en Europe le diagnostic des infections respiratoires et pharyngées au plus près du patient

  • Published on 03/19/2026 at 07:00, 6 hours 15 minutes ago

    Résultats annuels 2025 et nouvelle signature stratégique

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy